Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Jové M, Salla J, Planavila A, Cabrero A, Michalik L, Wahli W, Laguna JC and Vazquez M.

    Impaired expression of NADH dehydrogenase subunit 1 and PPARgamma coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone.

    JOURNAL OF LIPID RESEARCH . 45(1): 113-123. Nº de citas: 51

    [doi:10.1194/jlr.M300208-JLR200]

  • Sanguino E, Ramón M, Michalik L, Wahli W, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha.

    BIOCHEMICAL PHARMACOLOGY . 67(1): 157-166. Nº de citas: 34

    [doi:10.1016/j.bcp.2003.08.034]

  • Sanguino E, Ramón M, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe.

    LIFE SCIENCES . 73(23): 2927-2937. Nº de citas: 9

    [doi:10.1016/j.lfs.2003.04.001]

  • Cabrero A, Jové M, Planavila A, Merlos M, Laguna JC and Vazquez M.

    Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.

    MOLECULAR PHARMACOLOGY . 64(3): 764-772. Nº de citas: 21

    [doi:10.1124/mol.64.3.764]

  • Llaverías G, Jové M, Vazquez M, Sánchez RM, Díaz C, Hernández G, Laguna JC and Alegret M.

    Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages.

    EUR J PHARMACOL . 451(1): 11-17. Nº de citas: 21

    [doi:10.1016/S0014-2999(02)02152-0]